At Diagnose Early, our mission is to reduce human suffering and provide valuable
healthcare insights by performing non-invasive breath biopsies for biomarkers of mass market diseases, including cancers, neurological diseases, infections diseases, Long Covid, toxins, and more.
We also leverage cutting edge technology to support difficult-to-resolve healthcare
conditions on a massive scale, through the use of customized medical wearables to analyze massive volumes of data though our Al driven Health Data Platform that could support the development of breakthrough interventional therapeutics for the diseases we study.